Relapse: Clinical Trials

2 trials for Relapse, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 withdrawn. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Withdrawn 2
Phase 31Withdrawn 1

Follow Relapse: new trials by email Literature Review of Relapse trials Research Report on Relapse

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Primaquine Double Dose for Radical Cure of Plasmodium Vivax in Colombia
Primaquine double dose over 14 days, Primaquine single dose over 14 days - Malaria, Vivax, Relapse
Phase 2 / Phase 3WithdrawnUniversity of California, San Francisco2023-01-202023-05-11
"The Evaluation of Stimulant Withdrawal"
Coreg - Anxiety, Relapse
Phase 2WithdrawnAaron J. Janowsky2007-07-012019-01-31

Narrower conditions

Recurrence (2)  ·  Anxiety Disorders (1)  ·  Malaria, Vivax (1)  ·  Substance-Related Disorders (1)

Broader conditions

Disease Attributes (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Chemically-Induced Disorders (1)  ·  Infections (1)  ·  Malaria (1)  ·  Mental Disorders (1)  ·  Mosquito-Borne Diseases (1)  ·  Parasitic Diseases (1)  ·  Protozoan Infections (1)  ·  Vector Borne Diseases (1)

Interventions

Carvedilol (1)  ·  Primaquine (1)

Sponsors

Aaron J. Janowsky (1)  ·  University of California, San Francisco (1)

Countries

United States (1)

Top investigators

Paul S Berger, M.D. (1)

NIH funding

P50DA018165 (1)